283 related articles for article (PubMed ID: 28456081)
1. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
2. Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide.
Jiang Q; Rao X; Kim CY; Freiser H; Zhang Q; Jiang Z; Li G
Int J Cancer; 2012 Feb; 130(3):685-93. PubMed ID: 21400505
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E γ-Tocotrienol Inhibits Cytokine-Stimulated NF-κB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids.
Wang Y; Park NY; Jang Y; Ma A; Jiang Q
J Immunol; 2015 Jul; 195(1):126-33. PubMed ID: 26002975
[TBL] [Abstract][Full Text] [Related]
4. γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of sphingolipid transport.
Palau VE; Chakraborty K; Wann D; Lightner J; Hilton K; Brannon M; Stone W; Krishnan K
BMC Cancer; 2018 May; 18(1):564. PubMed ID: 29769046
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E metabolite 13'-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice.
Jang Y; Park NY; Rostgaard-Hansen AL; Huang J; Jiang Q
Free Radic Biol Med; 2016 Jun; 95():190-9. PubMed ID: 27016075
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.
Yang C; Jiang Q
J Nutr Biochem; 2019 Feb; 64():101-109. PubMed ID: 30471562
[TBL] [Abstract][Full Text] [Related]
7. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
[TBL] [Abstract][Full Text] [Related]
8. Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells.
Gopalan A; Yu W; Jiang Q; Jang Y; Sanders BG; Kline K
Mol Nutr Food Res; 2012 Dec; 56(12):1803-11. PubMed ID: 23065795
[TBL] [Abstract][Full Text] [Related]
9. The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis.
Schiffmann S; Sandner J; Schmidt R; Birod K; Wobst I; Schmidt H; Angioni C; Geisslinger G; Grösch S
J Lipid Res; 2009 Jan; 50(1):32-40. PubMed ID: 18711209
[TBL] [Abstract][Full Text] [Related]
10. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
11. Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia.
Testai FD; Kilkus JP; Berdyshev E; Gorshkova I; Natarajan V; Dawson G
J Neurochem; 2014 Nov; 131(4):530-40. PubMed ID: 25060904
[TBL] [Abstract][Full Text] [Related]
12. Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy.
Gagliostro V; Casas J; Caretti A; Abad JL; Tagliavacca L; Ghidoni R; Fabrias G; Signorelli P
Int J Biochem Cell Biol; 2012 Dec; 44(12):2135-43. PubMed ID: 22960157
[TBL] [Abstract][Full Text] [Related]
13. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.
Casasampere M; Ordóñez YF; Casas J; Fabrias G
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925
[TBL] [Abstract][Full Text] [Related]
14. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
[TBL] [Abstract][Full Text] [Related]
15. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells.
Ridgway ND; Merriam DL
Biochim Biophys Acta; 1995 Apr; 1256(1):57-70. PubMed ID: 7742357
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
18. Natural forms of vitamin E and metabolites-regulation of cancer cell death and underlying mechanisms.
Jiang Q
IUBMB Life; 2019 Apr; 71(4):495-506. PubMed ID: 30548200
[TBL] [Abstract][Full Text] [Related]
19. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells.
Signorelli P; Munoz-Olaya JM; Gagliostro V; Casas J; Ghidoni R; Fabriàs G
Cancer Lett; 2009 Sep; 282(2):238-43. PubMed ID: 19394759
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
